IRADIMED CORP - 8-K Filing
IRADIMED reported Q2 revenue of $20.5M, flat YoY; reaffirmed full-year guidance and declared a $0.20/share dividend. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $IRMD